Latest LFA Collective Data Analysis Initiative (CDAI) study yields important results and was recently published in the premier rheumatology journal, Arthritis and Rheumatology.
This data comes as welcome news for patients with lupus-related kidney disease.
The Foundation is currently accepting applications from lupus investigators and student researchers for our Career Development and Student Summer Fellowship grant programs.
In a victory for research advocates, on December 13, President Barack Obama signed the 21st Century Cures Act into law.
Fast Track is a process designed to expedite FDA review and get important new drugs to the patient earlier.
Lupus is the feature of a new publication by the largest non-profit alliance committed to making medical research a national priority.
This week, LFA-supported researchers will share results of a study that could help expedite the delivery of new and safer therapies to people with lupus.
Aurinia Pharmaceuticals announced its plans for a single Phase III clinical trial for voclosporin in the treatment of lupus nephritis.